Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Acquisition Should Increase Routine Flow Cytometry Diagnostic Use in Research and Clinical Practice

By BiotechDaily International staff writers
Posted on 13 Aug 2013
Image: The MoFlo XDP flow cytometer has set the standard for cell sorting with functionality, speed, and improved sensitivity (Photo courtesy of Beckman Coulter Life Sciences).
Image: The MoFlo XDP flow cytometer has set the standard for cell sorting with functionality, speed, and improved sensitivity (Photo courtesy of Beckman Coulter Life Sciences).
A major American producer of instruments for biomedical testing has acquired access to flow cytometry reagents that were among the first of this genre to be both dry and temperature-stable with CE marking for routine in vitro diagnostic use in Europe.

Beckman Coulter Life Sciences (Indianapolis, IN, USA), which develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing has acquired the flow cytometry business assets of the life science technology company ReaMetrix India Pvt. Ltd. (Bangalore, India).

Beckman Coulter Life Sciences' diagnostic systems are found in hospitals and other critical care settings around the world and generate data used by physicians to diagnose disease, make treatment decisions, and monitor patients. In the research sector, their instruments have been applied to complex biological problems including causes of disease and potential new therapies or drugs. Acquisition of ReaMetrix is expected to help Beckman Coulter to widen its tool and technology offerings that would simplify the sample preparation process and provide highly standardized reagent combinations to cytometry laboratories around the globe. The deal provides it with temperature-stable, single-dose, multi-color antibody cocktails targeting two key segments for flow cytometry - HIV monitoring and clinical research.

“This acquisition provides both immediate opportunity and long-term value,” said Mario Koksch, vice president and general manager of the cytometry business unit at Beckman Coulter Life Sciences. “The simplification of customer workflows will be dramatic. We will be able to offer customers an extended line of market leading technology while expanding our reach within two key segments for flow cytometry—HIV monitoring and clinical research.”

“Over the last decade, ReaMetrix has been developing technologies that improve access of diagnostic testing through innovation,” said Bala S. Manian, CEO of ReaMetrix India Pvt. Ltd. “The development of room temperature stable unitized flow reagents used in diagnostics and life sciences is an important component of that effort. For ReaMetrix, Beckman Coulter Life Sciences represents an opportunity to provide the global customer with an integrated and optimized solution involving both hardware and reagents. From our point of view, we now have the best chance of benefiting the intended target population as well as impacting the productivity of cytometrists around the world. ”

Related Links:
Beckman Coulter Life Sciences
ReaMetrix India Pvt. Ltd.


WATERS CORPORATION

Channels

Genomics/Proteomics

view channel
Image: Electron micrograph of Hepatitis C virus purified from cell culture. Scale bar is 50 nanometers (Photo courtesy of the Center for the Study of Hepatitis C, the Rockefeller University).

Oxidized LDL Predicts Response to Interferon Treatment of Chronic Hepatitis C and May Be a Treatment Option

Oxidized low-density lipoprotein (oxLDL) in the blood was shown to predict responsiveness to interferon treatment in patients with chronic Hepatitis C virus (HCV) infection and to inhibit spread of the... Read more

Drug Discovery

view channel
Image: Molecular model of the anti-cancer drug 5-fluorouracil (Photo courtesy of Wikimedia Commons).

Novel Microcapsule Approach Reduces Toxic Side Effects of Chemotherapy

Cancer researchers have reduced chemotherapy's toxic side effects by using nanoporous capsules to transport an enzyme to the site of a tumor where it is activated by a selective heating process to convert... Read more

Lab Technologies

view channel
Image: The gene assembly robot, the GeneTheatre (Photo courtesy of Analytik Jena AG).

Genomic Research Laboratories Await New Compact Liquid Handling System

A small footprint benchtop liquid handler that automates multiple gene assembly tasks and associated procedures such as PCR setup is now available for use by biotech and genomic research laboratories.... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

02 Jun 2015 - 03 Jun 2015
15 Jun 2015 - 18 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.